Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested

Contact Dermatitis. 2010 Aug;63(2):107-8. doi: 10.1111/j.1600-0536.2010.01750.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma, Bronchiolo-Alveolar / complications*
  • Adrenal Cortex Hormones / therapeutic use
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Breast Neoplasms / complications*
  • Drug Hypersensitivity / diagnosis*
  • Drug Hypersensitivity / drug therapy
  • Drug Hypersensitivity / etiology
  • Enoxaparin / adverse effects
  • Enoxaparin / therapeutic use
  • Female
  • Fondaparinux
  • Histamine Antagonists / therapeutic use
  • Humans
  • Hypersensitivity, Delayed / diagnosis*
  • Hypersensitivity, Delayed / drug therapy
  • Hypersensitivity, Delayed / etiology
  • Lung Neoplasms / complications*
  • Middle Aged
  • Nadroparin / adverse effects
  • Nadroparin / therapeutic use
  • Patch Tests
  • Polysaccharides / adverse effects*
  • Polysaccharides / therapeutic use
  • Treatment Outcome
  • Vena Cava, Superior*
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / etiology

Substances

  • Adrenal Cortex Hormones
  • Anticoagulants
  • Enoxaparin
  • Histamine Antagonists
  • Nadroparin
  • Polysaccharides
  • Fondaparinux